InvestorsHub Logo
Followers 93
Posts 7617
Boards Moderated 0
Alias Born 08/19/2009

Re: RSI38 post# 580

Sunday, 03/03/2019 6:59:56 PM

Sunday, March 03, 2019 6:59:56 PM

Post# of 1106
At the end of the fiscal year, Immunogen Inc has the cash and cash equivalents of $262.3 million, compared with $267.1 million in the previous year. The company had no long term debt, compared with $2.05 million in the previous year. Immunogen Inc has a financial strength rank of 5 (out of 10).

At the current stock price of $2.51, Immunogen Inc is traded at 73.7% discount to its historical median P/S valuation band of $9.54.



IMGN
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News